Apellis Pharmaceuticals Inc (APLS)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$25.21

Buy

$26.20

arrow-up$0.265 (+1.06%)

Prices updated at 12 Dec 2025, 22:53 EST

Prices minimum 15 mins delay

Prices in USD

Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$25.28 - $24.45
	$35.71 - $16.10
	-
	3,192.23m
	70.08
	-
	1,581,896
	7.96
	2,365,232.96
	-0.09
	124.50m
	US03753U1060
	0.36
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.